Azacyclic FTY720 Analogues That Limit Nutrient Transporter Expression but Lack S1P Receptor Activity and Negative Chronotropic Effects Offer a Novel and Effective Strategy to Kill Cancer Cells in Vivo

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 14, 2015
Source ID
10.1021/acschembio.5b00761

Entities

People

  • Aimee L Edinger
  • Alison N. Mccracken
  • Andrea Huwiler
  • Andrew Keebaugh
  • Bin Chen
  • Daniel Fallegger
  • Elizabeth Selwan
  • Michael T. Kleinman
  • Rebecca Fransson
  • Ryan J. Mcmonigle
  • Saurabh G. Roy
  • Stephen Hanessian

Organizations

  • American Cancer Society
  • Congressionally Directed Medical Research Programs
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • University of Bern
  • University of California, Irvine
  • Université de Montréal